Coloplast B A/S (COLO-B.CO) Financials
COLO-B.CO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 48.6 billion | 33.5 billion |
| 2023-09-30 | 48.2 billion | 30.9 billion |
| 2023-06-30 | 35.1 billion | 28.6 billion |
| 2023-03-31 | 35.3 billion | 28.3 billion |
COLO-B.CO Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | 1.5 billion | ? |
| 2023-09-30 | 1.5 billion | ? |
| 2023-06-30 | 878.0 million | ? |
| 2023-03-31 | 398.0 million | ? |
COLO-B.CO Net Income
| Date | Net Income |
|---|---|
| 2023-12-31 | 1.2 billion |
| 2023-09-30 | 1.2 billion |
| 2023-06-30 | 1.7 billion |
| 2023-03-31 | 1.7 billion |
COLO-B.CO Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | 885.0 million |
| 2023-09-30 | - | - | 894.0 million |
| 2023-06-30 | 855.0 million | - | 896.0 million |
| 2023-03-31 | 644.0 million | - | 869.0 million |
COLO-B.CO Shares Outstanding
COLO-B.CO Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 276.0 million | 233.0 million | 2.5 billion | - |
| 2023-09-30 | 384.0 million | 231.0 million | 2.2 billion | - |
| 2023-06-30 | 291.0 million | 216.0 million | 262.0 million | 1.9 billion |
| 2023-03-31 | 291.0 million | 209.0 million | 277.0 million | 1.9 billion |
COLO-B.CO Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 6.6 billion | 2.1 billion |
| 2023-09-30 | 6.2 billion | 2.1 billion |
| 2023-06-30 | 6.1 billion | 2.1 billion |
| 2023-03-31 | 6.1 billion | 2.0 billion |
COLO-B.CO
Price: DKK849.20
Dividend Yield: 0.02%
Forward Dividend Yield: 3.80%
Payout Ratio: 143.43%
Dividend Per Share: 32.00 DKK
Earnings Per Share: 22.31 DKK
P/E Ratio: 40.19
Exchange: CPH
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 509391
Market Capitalization: 205.6 billion
Average Dividend Frequency: 1
Years Paying Dividends: 36
DGR3: 5.27%
DGR5: 5.59%
DGR10: 2.85%
DGR20: 29.59%